DuPont de Nemours/$DD

1D1W1MYTD1Y5YMAX

About DuPont de Nemours

DuPont is a diversified global specialty chemicals company created in 2019 as a result of the DowDuPont merger and subsequent separations. Its portfolio includes specialty chemicals and downstream products that serve the healthcare, water, construction, automotive, aerospace, and printing and packaging industries. Healthcare and water will generate the majority of profits.
Ticker
$DD
Primary listing
NYSE
Employees
15,000

DD Metrics

BasicAdvanced
$17B
319.11
$0.39
1.09
$0.60
0.64%

Bulls say / Bears say

DuPont exceeded second-quarter expectations and raised full-year 2026 guidance, with sales up 4%, organic sales up 4%, adjusted EPS up 48% year over year, and operating EBITDA up 6%. (DuPont)
Healthcare & Water Technologies is delivering attractive growth and profitability: second-quarter organic sales increased 4%, Healthcare Technologies grew mid-single digits organically, and the segment generated a 30.1% operating EBITDA margin. (DuPont)
Cash generation and portfolio monetization support shareholder returns and financial flexibility. Second-quarter transaction-adjusted free-cash-flow conversion was 127%, while the Aramids sale generated approximately $1.2 billion in cash proceeds plus a $300 million note receivable and $325 million equity interest. (DuPont)
Diversified Industrials remains exposed to weak construction demand: first-quarter organic sales were approximately flat, with Building Technologies down low-single digits and printing and packaging also declining. (DuPont)
Portfolio restructuring creates execution and comparability risk: DuPont completed the Aramids divestiture in April 2026 and the Qnity electronics separation remains reflected as discontinued operations, while separation and restructuring-related payments continued during the first half. (SEC filing)
Geopolitical and trade risks could pressure future results. DuPont cited Middle East-related weakness in Water Technologies, higher input costs requiring pricing actions, and uncertainty around the ultimate impact of tariff litigation and refunds. (SEC filing)
Data summarised monthly by Lightyear AI. Last updated on 14 Sept 2026.

Funds containing DD

AllEURGBPUSD
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.